dactinomycin has been researched along with vancomycin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Herdewijn, P; Maiti, M; Nauwelaerts, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Veerkamp, JH | 1 |
| Van Schaik, FW; Veerkamp, JH | 1 |
| Hawiger, J; Jeljaszewicz, J | 1 |
| Cohen, M; Fagan, G; Panos, C | 1 |
| Russell, AD | 1 |
| Lazdunski, C; Shapiro, BM | 1 |
| Miller, LL; Ordal, ZJ | 1 |
| Bosmann, HB; Winston, RA | 1 |
| Hall, HH; Jackson, RW; Pridham, TG | 1 |
| Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A | 1 |
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Asari, S; Horikawa, M; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M; Tsukamoto, H; Ueda, A | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
2 review(s) available for dactinomycin and vancomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The mechanism of action of some antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Bacitracin; Bacteria; Cell Membrane; Cell Wall; Cephalosporins; Chloramphenicol; Cycloserine; Dactinomycin; Edetic Acid; Lysostaphin; Metals; Mitomycins; Mucoproteins; Muramidase; Nalidixic Acid; Novobiocin; Nucleic Acids; Penicillins; Peptide Biosynthesis; Phenols; Polymyxins; Puromycin; Quaternary Ammonium Compounds; Ristocetin; Streptomycin; Tetracycline; Vancomycin | 1969 |
17 other study(ies) available for dactinomycin and vancomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional | 2012 |
Biochemical changes in Bifidobacterium bifidum var. pennsylvanicus after cell wall inhibition. IX. Metabolism and release of cellular lipids in the presence of antibiotics.
Topics: Actinomycetaceae; Animals; Anti-Bacterial Agents; Bacitracin; Cell Wall; Chloramphenicol; Culture Media; Cycloserine; Dactinomycin; Glycolipids; Milk; Penicillins; Phospholipids; Streptomycin; Tetracycline; Valinomycin; Vancomycin | 1976 |
Biochemical changes in Bifidobacterium bifidum var. pennsylvanicus after cell wall inhibition. VIII. Composition and metabolism of phospholipids at different stages and conditions of growth.
Topics: Bacitracin; Bacteria; Cell Division; Cell Wall; Chloramphenicol; Culture Media; Cycloserine; Dactinomycin; Female; Humans; Hydrogen-Ion Concentration; Milk, Human; Penicillin G; Phospholipids; Pregnancy; Streptomycin; Time Factors; Vancomycin | 1975 |
Antibiotic sensitivity of Micrococcus radiodurans.
Topics: Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Dactinomycin; Dihydrostreptomycin Sulfate; Erythromycin; Kanamycin; Micrococcus; Mitomycins; Neomycin; Penicillin G; Penicillin Resistance; Vancomycin | 1967 |
Antibiotic inhibition and binding studies with a group A streptococcal L-form.
Topics: Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Cycloserine; Dactinomycin; L Forms; Novobiocin; Penicillin G; Polymyxins; Puromycin; Ristocetin; Streptococcus pyogenes; Tritium; Vancomycin | 1967 |
Isolation and some properties of cell envelope altered mutants of Escherichia coli.
Topics: Bacitracin; Bile Acids and Salts; Cell Division; Cell Membrane Permeability; Colicins; Colistin; Culture Media; Dactinomycin; Drug Resistance, Microbial; Escherichia coli; Genetics, Microbial; Lactose; Microbial Sensitivity Tests; Mutagens; Mutation; Peptidoglycan; Polymyxins; Sodium Dodecyl Sulfate; Vancomycin | 1972 |
Thermal injury and recovery of Bacillus subtilis.
Topics: Bacillus subtilis; Carbon Isotopes; Cell Survival; Chloramphenicol; Culture Media; Dactinomycin; Electrophoresis, Polyacrylamide Gel; Hot Temperature; Micropore Filters; Nalidixic Acid; Nucleic Acid Denaturation; Penicillin G; Penicillin Resistance; Polymyxins; RNA, Bacterial; RNA, Ribosomal; Sodium Chloride; Time Factors; Tritium; Uracil; Vancomycin | 1972 |
Antibiotics and macromolecular synthesis in microsomes and mitochondria. I. Antibiotics acting in the same manner in mitochondria and microsomes.
Topics: Animals; Anti-Bacterial Agents; Carbon Isotopes; Cerebral Cortex; Dactinomycin; Daunorubicin; Glycoproteins; Guanosine Triphosphate; In Vitro Techniques; Leucomycins; Male; Metabolism; Microsomes; Microsomes, Liver; Mitochondria; Mitochondria, Liver; Mitomycins; Oleandomycin; Oligomycins; Protein Biosynthesis; Puromycin; Rats; Streptomycin; Vancomycin | 1972 |
Effect of antimicrobial agents on the milky disease bacteria Bacillus popilliae and Bacillus lentimorbus.
Topics: Anti-Bacterial Agents; Bacillus; Culture Media; Cycloheximide; Dactinomycin; In Vitro Techniques; Ristocetin; Sulfonamides; Vancomycin | 1965 |
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin | 1997 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Therapy, Combination; In Vitro Techniques; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2003 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |